Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Immunol Rev. 2016 Jan;269(1):145–161. doi: 10.1111/imr.12344

Table 1.

Phenotypes of genetically altered mice with presumed alterations in the CD22 pathway

B-cell populations B-cell surface phenotype Signalling (anti-IgM) Mouse

Mouse strain Genetic Background MZ B1 Recirc. sIgM MHC II CD22 Ca2+ Prolif. Apop. Serum IgM Td Ti AutoAb Reference

CD22−/− mixed 129 × B6 (from 129 ES cells) n.a. ← → Yes (1 of 3 lines) 46, 133, 134
CD22−/− B6, (from B6 ES cells) ← → n.a. ← → ↑ (> 5 mo) ← → No 30

CD22Δ1-2 Backcrossed to B6 for 6 generations. ← → n.d. n.d. n.d. n.d. n.d. 55
CD22AA ← → n.d. n.d. n.d. n.d. n.d. 55
CD22a.B6 B6 (congenic with NZB CD22a allotype) ← → n.d. n.d. ← → n.d. n.d. n.d. n.d. Yes (Coombs Ab) 65
CD22 R130E B6 ← → n.d. n.d. ← → n.d. n.d. ← → ← → ← → n.d. 39
CD22 ITIM mutant B6 ← → n.d. n.d. ← → n.d. n.d. ← → n.d. 39

ST6Gal I−/− Backcrossed to B6 for 6 generations from 129. ← → ↓ ↓ ← → n.d. n.d. 65, 135, 136
ST6Gal I−/− × CD22−/− ← → ↓ ↓ n.d n.a. n.d. n.d. n.d. n.d. n.d. 137

SIAE−/− mixed 129 × B6 (from 129 ES cells) n.d. ← → n.d ← → Yes 19
CMAH−/− 2 lines: B6, mixed 129/B6 n.d. ← → ← → ← → n.d. ← → ← → n.d. 91, 138

Note: This an expanded and updated version of a summary table originally presented in a review by Smith et al (11). Td = T-dependent; Ti = T-independent; AutoAb = autoantibody; B6 = C57/BL6; sIgM = surface IgM; n.d = not determined; n.a. = not applicable.